LRF Releases 2022 Public Policy Agenda Outlining Priorities for Year Ahead

The Lymphoma Research Foundation (LRF) is proud to be a national thought leader and advocate for policies and legislation that will improve the lives of people with lymphoma and chronic lymphocytic leukemia (CLL). LRF leads efforts to ensure the needs and perspectives of the lymphoma community are considered and integrated into public policy at the federal level.

The Public Policy Agenda outlines LRF’s policy priorities for the year ahead and will direct the efforts of thousands of patient and caregiver advocates across the United States. This year, the Foundation will prioritize increasing funding for the National Institutes of Health and the National Cancer Institute, including enhanced support for lymphoma research and the nation’s clinical trials enterprise. The Foundation will also support legislation and regulations which seek to increase access to comprehensive lymphoma treatment and cancer survivorship care, recognizing the increased number of cancer survivors in the United States and the needs of people living with and after a lymphoma diagnosis.